In its original complaint, Louisiana argued the Biden administration expanded access to mifepristone without properly considering potential safety risks. The state also argued the policy violated the Comstock Act, which generally prohibits sending abortion drugs by mail.
Researchers noted that gaps in informed consent and post-abortion examination were more apparent in cases of mail-order mifepristone.
The Supreme Court says rules that allow patients to get the abortion pill mifepristone through the mail can stay the same for at least a week.
State of the Union: The court ruled that allowing the pills to be mailed undermines the state’s abortion law. The post FDA Blocks Mail Distribution of Abortion Pills appeared first on The American Conservative .
A federal appeals court on Friday blocked the mailing of mifepristone prescriptions, sharply curtailing access to one of the most common methods of abortion in the United States. The unanimous ruling by a three-judge panel of the Fifth U.S. Circuit Court of Appeals requires the abortion pill to be dispensed only in person at clinics, overruling Food and Drug Administration regulations that allowed it to be distributed by mail. Judge Kyle Duncan wrote that mailing the drug into Louisiana undermines the state’s abortion ban. Danco Laboratories, the manufacturer of mifepristone, has appealed to the U.S. Supreme Court to overturn the decision. The Supreme Court unanimously ruled against an attempt by pro-life groups to restrict access…Open
The Fifth Circuit Court’s ruling, which is being appealed, reinstates a requirement that patients visit a health care provider in person to obtain mifepristone, upending abortion access in the United States.
A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone.
An appeals court issued a nationwide order barring dispensation of the abortion pill mifepristone by telehealth providers and distribution of the medication by mail.
A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone
A panel of the 5th U.S. Circuit Court of Appeals in New Orleans ruled that the state would likely succeed in its challenge to the federal rule that was adopted under the Biden administration.